You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

CEFACLOR Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Cefaclor patents expire, and what generic alternatives are available?

Cefaclor is a drug marketed by Ceph Intl, Chartwell Rx, Dava Pharms Inc, Hikma, Ivax Sub Teva Pharms, Ranbaxy, Teva, Yung Shin Pharm, Facta Farma, Watson Labs Inc, and World Gen. and is included in twenty-nine NDAs.

The generic ingredient in CEFACLOR is cefaclor. There are thirteen drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the cefaclor profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Cefaclor

A generic version of CEFACLOR was approved as cefaclor by TEVA on September 4th, 2002.

  Try a Trial

Drug patent expirations by year for CEFACLOR
Drug Prices for CEFACLOR

See drug prices for CEFACLOR

Recent Clinical Trials for CEFACLOR

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Fundacion Clinic per a la Recerca BiomédicaPhase 4
James Graham Brown Cancer CenterEarly Phase 1
Julio RamirezEarly Phase 1

See all CEFACLOR clinical trials

Pharmacology for CEFACLOR
Medical Subject Heading (MeSH) Categories for CEFACLOR

US Patents and Regulatory Information for CEFACLOR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Yung Shin Pharm CEFACLOR cefaclor FOR SUSPENSION;ORAL 065412-003 Feb 17, 2012 RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Ranbaxy CEFACLOR cefaclor FOR SUSPENSION;ORAL 064165-001 Oct 2, 1997 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
World Gen CEFACLOR cefaclor TABLET, EXTENDED RELEASE;ORAL 065057-001 Jan 5, 2001 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Ivax Sub Teva Pharms CEFACLOR cefaclor FOR SUSPENSION;ORAL 064086-001 Apr 28, 1995 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Ranbaxy CEFACLOR cefaclor FOR SUSPENSION;ORAL 064164-001 Oct 2, 1997 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Ivax Sub Teva Pharms CEFACLOR cefaclor FOR SUSPENSION;ORAL 064085-001 Apr 28, 1995 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.